*Therapeutic Approach to NAFLD-NASH DOI: http://dx.doi.org/10.5772/intechopen.107487*

**Figure 3.** *Pathways in metabolism where pharmaceutical interventions are made.*

could not identify a target with important clinical result for the patients (e.g., noncompensated liver cirrhosis), instead referring to certain objective findings, e.g., levels of aminotransferases or histologic findings, often with conflicting results.
